Divestment of Silkeborg Data (DK) to Axcel (DK) by Jyske Bank (DK) — Amount not disclosed FIG Divestment of Silkeborg Data (DK) to Axcel (DK) by Jyske Bank (DK) — Amount not disclosed
Acquisition of Kjell & Company (SE) by FSN Capital (SE) — Amount not disclosed Consumer & Retail Acquisition of Kjell & Company (SE) by FSN Capital (SE) — Amount not disclosed
Secondary placing of shares in Betsson (SE) — SEK 153 million TMT Secondary placing of shares in Betsson (SE) — SEK 153 million
Secondary placing of shares in Peab (SE) — SEK 186 million Real Estate Secondary placing of shares in Peab (SE) — SEK 186 million
Directed new share issue in Biotec Pharmacon ASA (NO) — NOK 78 million Healthcare Directed new share issue in Biotec Pharmacon ASA (NO) — NOK 78 million
Initial public offering of Recipharm (SE) on NASDAQ OMX Stockholm — SEK 1.5 billion Healthcare Initial public offering of Recipharm (SE) on NASDAQ OMX Stockholm — SEK 1.5 billion
Divestment of Phase One A/S (DK) to Silverfleet Capital (UK) — Amount not disclosed Industrials Divestment of Phase One A/S (DK) to Silverfleet Capital (UK) — Amount not disclosed
Secondary placing of of treasury shares in Fastighets AB Balder (SE) — SEK 221 million Real Estate Secondary placing of of treasury shares in Fastighets AB Balder (SE) — SEK 221 million
Private placement of shares in Glo AB – USD 30 million TMT Private placement of shares in Glo AB – USD 30 million
Acquisition of Oranje Casino and Kroon Casinos (MT) by Betsson (SE) — EUR 145 million TMT Acquisition of Oranje Casino and Kroon Casinos (MT) by Betsson (SE) — EUR 145 million
Directed new share issue in Oasmia Pharmaceutical AB (SE) — SEK 72 million Healthcare Directed new share issue in Oasmia Pharmaceutical AB (SE) — SEK 72 million
Secondary placing of shares in FinnvedenBulten AB (SE) — SEK 314 million Industrials Secondary placing of shares in FinnvedenBulten AB (SE) — SEK 314 million